Jupiter Life Line Hospitals Ltd Q4 FY2026 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/fzoud9ce88r83ov2av75rg4y.pdf

Key Takeaways


Dombivli: The Next Growth Engine

Thakker: "We built 750,000 square feet, the entire superstructure for 500 beds and completed fit outs for approximately 300 beds, all in just over 24 months. And we did it without any cost escalations on time, on budget, no surprises."

Unit-Level Dynamics

UnitOccupancyGrowth Drivers
Thane~75%Mature asset; inflation-linked growth expected at current capacity.
Pune~65%Headroom for occupancy growth plus inflation-linked pricing.
Indore45–50%All three levers active: occupancy ramp, case-mix improvement, and inflation. Added capacity last year still absorbing; near-maturity expected in 2–3 years.

ARPOB & Revenue Mix


The Greenfield Pipeline

Thakker: "BKC is one of the most prominent addresses in the country. Putting up a 400-bed quaternary care hospital on over 1 lakh square feet of land there, is not just another hospital. It's a declaration that Jupiter is ready to compete at the very highest levels in India's most consequential health care market."

Costs & Risks

Thakker: "We are not trying to just grow fast. We are trying to grow right. Every project in our pipeline is greenfield. Each one is designed as a full-scale hub, not a spoke, not a satellite, but a flagship facility in its own right."

Guidance & Commitments

CommitmentSpecificsTimeline
Dombivli breakevenAchieve breakeven at the hospital levelEnd of year 2 of operations (calendar year-end 2027/2028)
Dombivli accreditation & insuranceNABH accreditation and insurance empanelment completedWithin 6–12 months
Pune South openingHospital operationalCalendar year 2028
Mira Road construction startExcavation beginsBy end of this year
BKC land paymentRemaining 75% of land cost paidThis financial year
Thane expansion approvalsFinal regulatory approvals receivedSometime this financial year
Indore Phase 2 trigger111-bed expansion consideredWhen occupancy crosses or nears 60%
Leverage ceilingDebt kept under 3x EBITDA to fund all announced projectsOver next 4–5 years

Key Metrics

MetricQ4 FY26
Total income (FY26)₹1,499.8 cr, up 15.2% YoY
Q4 revenue₹387.8 cr, up 15.1%
EBITDA (FY26)₹343.3 cr, up 14.4% YoY, margin 22.9%
Q4 EBITDA₹89.2 cr, margin 23%
PAT (FY26)₹194.2 cr
Q4 PAT₹50.2 cr, up 11.5%
ARPOB₹67,700, up 11.7%
ALOS3.87 days
Bed occupancy (3 pre-existing hospitals)61.2%
Overall volumes10.8 lakhs, up 9.9%
Insurance revenue mix55.4% of revenue; government at 1%
Thane occupancy~75%
Pune occupancyclose to 65%
Indore occupancybetween 45% and 50%
Dombivli Q4 revenue contribution₹9.4 cr
Dombivli EBITDA burn₹2 cr to ₹3 cr per month on average for the full year
Capex deployed in FY26~₹500 cr
Gross debt~₹500 cr; cash on hand ~₹545 cr
Expansion cycle new beds1,700 beds at average cost of ~₹1.5 cr per bed; long-term capacity target nearly 3,000 beds
BKC land payment25% of land cost paid; remaining to be paid in this financial year